Investor Presentaiton slide image

Investor Presentaiton

2024 - 2025 Key Milestones CLINICAL REGULATORY COMMERCIAL LABEL & THERAPY EXPANSION 11 R&D Q1 2024 Q2 2024 Q3 2024 Q4 2024 2025 DREAM 12M data Module 4 - DREAM PMA Submission Commercial Team Team buildout DREAM FDA Approval US Launch ACCCESS Implant completion Genio 3.1 Regulatory Submission Genio 3.1 Approval ACCCESS 12M data Nyxoah
View entire presentation